This is a proprietary immunoglobin assay designed for point-of-care use to detect the presence of SARS-CoV-2 IgM and IgG antibodies in symptomatic patients. The test is very simple. Two drops of blood are taken from a patient's fingertip and placed in the specimen window of a test cassette, along with two drops of buffer solution. Results are available in 20 minutes.